Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 11/20 | 0.44 |
| ▸ | HTR7 | P34969 | 11/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 3/20 | 0.42 |
| ▸ | HTR6 | P50406 | 2/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4883056 | 0.83 | KMT2A (0.52) | HTR1AHTR7POLB | |
| SCHEMBL4885026 | 0.82 | MMP13 (0.42) | MMP13HTR1AHTR7EPHX2DRD2 | |
| SCHEMBL4602370 | 0.82 | MMP13 (0.63) | MMP13HTR1AHTR7NR1H2NR1H3 | |
| SCHEMBL4888091 | 0.80 | EPHX2 (0.55) | EPHX2 | |
| Hydrochloric Acid SCHEMBL4881423 | 0.79 | DPP4 (0.49) | HTR1AHTR7EPHX2RORCDPP4 | |
| Hydrochloric Acid SCHEMBL4881432 | 0.79 | DPP4 (0.49) | HTR1AHTR7EPHX2RORCDPP4 | |
| SCHEMBL4885197 | 0.78 | MMP2 (0.44) | HTR1AHTR7EPHX2 | |
| SCHEMBL4883757 | 0.77 | MMP3 (0.48) | — | |
| SCHEMBL6538880 | 0.75 | MEN1 (0.66) | HTR1AHTR7EPHX2DRD2HTR6 | |
| SCHEMBL13873237 | 0.74 | EPHX2 (0.56) | HTR1AHTR7EPHX2DRD2HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234333-A1 | Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof | KANG JAE-HOON | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234333-A1 | Novel Hydroxamic Acid Derivative as Peptide Deformylase Inhibitor and Manufacturing Method Thereof | PDF, PEPD, DHPS | MMP13 740/4885HTR1A 3793/4885HTR7 3840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.